Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer
Daniel R. Principe, Alexandre F. Aissa, Sandeep Kumar, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 18
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications
Shanliang Zheng, Xingwen Wang, Dong Zhao, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 312-323
Open Access | Times Cited: 144
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
Mingjian Ma, Yin-Hao Shi, Zhide Liu, et al.
Oncogene (2024) Vol. 43, Iss. 31, pp. 2405-2420
Open Access | Times Cited: 11
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 15
Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms
Mustafa B.A. Djamgoz
Cancers (2022) Vol. 14, Iss. 11, pp. 2703-2703
Open Access | Times Cited: 19
Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer
Jie Zhu, Ke Zhang, Chen Yuan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Translational regulation of SND1 governs endothelial homeostasis during stress
Zhenbo Han, Gege Yan, Jordan Jousma, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access
The first-line antihypertensive nitrendipine potentiated the therapeutic effect of oxaliplatin by downregulating CACNA1D in colorectal cancer
Chengzhe Lai, Jinghu Liu, Jingna Zhou, et al.
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model
Xinqi Li, Yueze Liu, Feihan Zhou, et al.
Cancer Letters (2025), pp. 217751-217751
Closed Access
The development of prognostic gene markers associated with disulfidptosis in gastric cancer and their application in predicting drug response
Xing Liu, Jianghong Ou
Heliyon (2024) Vol. 10, Iss. 4, pp. e26013-e26013
Open Access | Times Cited: 3
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer
Jeffrey H. Becker, Anastasia E. Metropulos, Christina Spaulding, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3629-3639
Open Access | Times Cited: 3
Harnessing the Engineered Probiotic‐Nanosystem to Remodulate Tumor Extracellular Matrix and Regulate Tumor‐Colonizing Bacteria for Improving Pancreatic Cancer Chemo‐Immunotherapy
Weiqin Yao, Wenfang Song, Xin‐Chen Deng, et al.
Small (2024)
Open Access | Times Cited: 3
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma
Keisuke Okuno, Caiming Xu, Silvia Pascual-Sabater, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 119-119
Open Access | Times Cited: 7
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 12
T-Type Calcium Channels: A Mixed Blessing
Dario Melgari, Anthony Frosio, Serena Calamaio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9894-9894
Open Access | Times Cited: 11
Small molecular inhibitors: Therapeutic strategies for pancreatic cancer
Yuvasri Golivi, Seema Kumari, Batoul Farran, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104053-104053
Closed Access | Times Cited: 2
Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer
Daniel R. Principe, Mary Pasquinelli, Ryan H. Nguyen, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2282-2294
Open Access | Times Cited: 2
Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations
Daniel R. Principe
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Calcium channel blockers are associated with improved survival in pancreatic cancer patients undergoing neoadjuvant chemotherapy and resection
Zhi Ven Fong, George R. Severs, John Moir, et al.
HPB (2023)
Open Access | Times Cited: 5
Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer
Ke Zhang, Chen Yuan, Jie Zhu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
EZH2 as a potential therapeutic target for gastrointestinal cancers
Mehrdad Hashemi, Naghmeh Nazdari, Ghazaleh Gholamiyan, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154988-154988
Closed Access | Times Cited: 4
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study)
Masahiro Hatori, Daiki Tsuji, K Suzuki, et al.
Cancer (2024) Vol. 130, Iss. 17, pp. 2988-2999
Closed Access | Times Cited: 1
Ca<sup>2+</sup> homeostasis: a potential target for cancer therapies
Su Min, Shanliang Zheng, Hao Liu, et al.
Biophysics Reports (2024) Vol. 10, pp. 1-1
Open Access | Times Cited: 1
The prevalence and impact of overweight and hypertension among patients with pancreatic cancer
Marta Fudalej, Izabella Cichowska, Anna Badowska-Kozakiewicz, et al.
Oncology in Clinical Practice (2024)
Open Access | Times Cited: 1
Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma
Natalia Kluz, Leszek Kraj, Paulina Chmiel, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3945-3945
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top